Oocyte lipid damage from maternal ageing marks neurodevelopment in mouse offspring
In brief
Age-related oocyte lipid changes persist through four mouse generations
In mice, oocytes from older mothers had altered lipid droplets and membranes, and related lipid and molecular signatures appeared in fetal brains and yolk sacs, persisting in descendants through the fourth generation. Embryo transfer to young surrogates suggests the pattern was not driven by an aging uterus, but the study measured molecular signatures, not neurodevelopmental disorders, and human relevance is unknown.
- Journal
- Human reproduction open (Q1)
- Published
- 19 October 2026
- Study design
- Unclassified
- Evidence level
- Level 5, Expert Opinion (CEBM 5)
- Authors
- Hafsa Gulzar, Richard Musson, Joanna Depciuch, Łukasz Gąsior, Simona Bisogno, Michał Sarna, et al.
- PMID
- 43032307
- DOI
- 10.1093/hropen/hoag096
Why clinicians should know about it
- Picked for Embryology (paper of the day, 16 November 2026): Animal study links oocyte lipid changes to fetal brain development
Abstract
STUDY QUESTION: Is advanced maternal age (AMA) associated with lipid dysregulation in oocytes that correlates with the intergenerational persistence of altered lipid homeostasis and neurodevelopmental pathway signatures in downstream offspring? SUMMARY ANSWER: Lipid profile alterations characterized in AMA oocytes are associated with distinct lipidomic and spectral variations in the foetal brain and yolk sac, displaying intergenerational persistence that extends up to the fourth generation (F4), independently of the gestational uterine environment. WHAT IS KNOWN ALREADY: AMA is a recognized prenatal risk factor for neurodevelopmental conditions in offspring. However, whether early-life oocyte lipid variations correlate with altered lipid profiles and molecular signatures in the developing brains of subsequent generations remain uncharacterized. STUDY DESIGN SIZE DURATION: This controlled animal model study compared oocytes, blastocysts, and foetuses from AMA mice (8-16 months old) to those from young maternal age (YMA, 3-4 months old) controls and featured an embryo transfer (ET) of AMA blastocysts into young surrogates and longitudinal, lineage-specific tracking up to the F4. PARTICIPANTS/MATERIALS SETTING METHODS: Complementary approaches, including liquid chromatography-mass spectrometry (LC-MS) proteomics and lipidomics, Matrix-Assisted Laser Desorption/Ionization-Tandem Time-of-Flight mass spectrometry (MALDI-TOF/TOF MS), RNA sequencing, atomic force microscopy, Coherent Anti-Stokes Raman Scattering (CARS) chemical imaging microscopy, Raman and Fourier transform infrared (FTIR) spectroscopies, and histology were conducted on single oocytes, blastocysts, and foetal structures (brain and yolk sac) from AMA and YMA mice. ET was utilized to decouple the oocyte-derived phenotype from the effects of an ageing maternal uterine environment. MAIN RESULTS AND THE ROLE OF CHANCE: AMA oocytes and preimplantation blastocysts exhibited significant lipid droplet and lipid membrane alterations, a higher relative absorbance of intracellular lipid bands, and altered expression of lipid-regulatory transcripts, corresponding to early embryonic pathway shifts. Following the ET of AMA blastocysts to young surrogates (ET AMA group), distinct lipidomic variations and structural alterations were observed in the F1 yolk sac and foetal brains. Furthermore, these lipid-associated spectral and molecular signatures displayed intergenerational persistence, tracking through the yolk sac, brain, and oocytes of the third- (F3) and fourth-generation (F4) descendants derived from the oocyte of AMA progenitors. LARGE SCALE DATA: The transcriptomic data have been deposited in the NCBI Gene Expression Omnibus (GEO) under accession number GSE349634. Processed transcriptomic, lipidomic, and proteomic datasets, together with the shared transcript-protein analysis, have been deposited in RODBUK under DOI https://doi.org/10.57903/UJ/LVQ7FU. All datasets are publicly available. LIMITATIONS REASONS FOR CAUTION: This study was conducted exclusively in a mouse model. Given species-specific variations in baseline oocyte lipid content and developmental kinetics, these findings require cautious interpretation before extrapolation to human clinical contexts. Additionally, the exact molecular and epigenetic mechanisms underlying the intergenerational persistence of these lipid signatures warrant further characterization. WIDER IMPLICATIONS OF THE FINDINGS: These findings demonstrate an association between early-life oocyte lipid changes and downstream pathway-level molecular signatures of neurodevelopmental alterations. By establishing an intergenerational pathway that persists independently of the maternal uterine environment, this work introduces a novel framework linking metabolic programming at conception to neurodevelopmental outcomes, offering new directions for reproductive medicine and translational neuroscience. FUNDING: This research was funded by National Science Centre of Poland Grants 2021/41/B/NZ3/03507 and 2019/35/B/NZ4/03547 (to G.E.P.), 2022/44/C/NZ4/00076 (to M.F.H.), and 2019/35/N/NZ3/03213 (to Ł.G.), and the program 'Excellence initiative-research university' for the AGH University of Krakow (A.B.-K.). Proteomics was supported by the subsidy no 16.16.160.557 of the Polish Ministry of Science and Higher Education (to P.S.). Raman analysis at the National Synchrotron Radiation Centre SOLARIS was supported by the Ministry of Science and Higher Education, Poland, under contract no. 1/SOL/2021/2. DISCLOSURES: The authors declare no competing interests.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.